NYSE : ZEPP
Zepp Health Corporation — Key statistics
Technology · Consumer Electronics · Netherlands
Last price 2.2 USD (Oct 30, 2026, 9:47 AM EDT) · Market cap 32.26M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 32.70M |
| Enterprise Value | 97.35M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 14.66M |
| Shares Change (YoY) | -1.04% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 35.38% |
| Owned by Institutions (%) | 15.44% |
| Float | 6.13M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.12 |
| Forward PS | n/a |
| PB Ratio | 0.19 |
| P/TBV Ratio | 0.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.90 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.41 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -21.23% |
| Return on Assets (ROA) | -3.92% |
| Return on Invested Capital (ROIC) | -13.37% |
| Return on Capital Employed (ROCE) | -14.17% |
| Weighted Average Cost of Capital (WACC) | 5.80% |
| Revenue Per Employee | $361,764 |
| Profits Per Employee | -$57,090 |
| Employee Count | 763 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.38 |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.51M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.81 |
| 52-Week Price Change | -94.48% |
| 50-Day Moving Average | 3.90 |
| 200-Day Moving Average | 10.07 |
| Relative Strength Index (RSI) | 13.53 |
| Average Volume (20 Days) | 62,378 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 334,821 |
| Short Previous Month | 321,131 |
| Short % of Shares Out | 5.21% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 14.09 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 276.03M |
| Gross Profit | 106.50M |
| Operating Income | -34.75M |
| Pretax Income | -41.05M |
| Net Income | -43.56M |
| EBITDA | -30.46M |
| EBIT | -34.75M |
| Loss Per Share | -$2.79 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 69.66M |
| Total Debt | 134.31M |
| Net Cash | -64.64M |
| Net Cash Per Share | -$4.41 |
| Equity (Book Value) | 184.97M |
| Book Value Per Share | 11.68 |
| Working Capital | -31.86M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | n/a |
| Capital Expenditures | -516,000 |
| Depreciation & Amortization | 4.29M |
| Net Borrowing | n/a |
| Free Cash Flow | -26.21M |
| FCF Per Share | -$1.79 |
Margins
| Measure | Value |
|---|
| Gross Margin | 38.58% |
| Operating Margin | -12.59% |
| Pretax Margin | -14.87% |
| Profit Margin | -15.78% |
| EBITDA Margin | -11.03% |
| EBIT Margin | -12.59% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.04% |
| Shareholder Yield | 1.04% |
| Earnings Yield | -125.00% |
| FCF Yield | -81.23% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 16, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.68 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |